Cite
Gunn S, Reveles X, Weldon K, et al. Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer. J Ovarian Res. 2013;6(1):2doi: 10.1186/1757-2215-6-2.
Gunn, S., Reveles, X., Weldon, K., Barrera, A., Ishaque, M., Taylor, D., McCaskill, C., Kim, J., Shah, R., Mohammed, M., Barry, T., Kaiser, B., Patnaik, A., & Tolcher, A. (2013). Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer. Journal of ovarian research, 6(1), 2. https://doi.org/10.1186/1757-2215-6-2
Gunn, Shelly, et al. "Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer." Journal of ovarian research vol. 6,1 (2013): 2. doi: https://doi.org/10.1186/1757-2215-6-2
Gunn S, Reveles X, Weldon K, Barrera A, Ishaque M, Taylor D, McCaskill C, Kim J, Shah R, Mohammed M, Barry T, Kaiser B, Patnaik A, Tolcher A. Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer. J Ovarian Res. 2013 Jan 04;6(1):2. doi: 10.1186/1757-2215-6-2. PMID: 23289505; PMCID: PMC3601995.
Copy
Download .nbib